GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Relmada Therapeutics RLMD · USD

Health Care · US listing · 🇺🇸 United States

Compare

4.14

+6.15%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Relmada Therapeutics

From its filings with the US Securities and Exchange Commission

SEC filings

Relmada Therapeutics is based in Coral Gables, Florida and is incorporated in Nevada. Its shares trade on Nasdaq under the ticker RLMD. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 August 2013, it reported revenue of $5,129.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
3 Mar 2014
Employees
17
Website
relmada.com ↗
Head office
2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
Incorporated in
NV
Classification
Pharmaceutical Preparations
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Mr. Charles CasamentoIndependent Chairman of the Board$353,608
  • Mr. Sergio TraversaChief Executive Officer, Director, since 2012$1.8m
  • Mr. Maged ShenoudaChief Financial Officer, since 2015$993,750
  • Mr. Paul KellyChief Operating Officer, Director, since 2015$872,780
  • Mr. Charles EnceChief Accounting, Compliance Officer$983,039
  • Ms. Fabiana FedeliIndependent Director$290,638
  • Mr. John GlasspoolIndependent Director$286,518
  • Mr. Tim McCarthyInvestor Relations, since 2020

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
48
Environment
48
Social
80
Governance
17
Women in the workforce
60%
Carbon reduction policy
No
Human rights policy
No

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Relmada Therapeutics Inc has several strengths that contribute to its competitive advantage:

Weaknesses

  • Despite its strengths, Relmada Therapeutics Inc also faces certain weaknesses that could hinder its growth:

Opportunities

  • Relmada Therapeutics Inc can leverage the following opportunities to expand its business:

Threats

  • Relmada Therapeutics Inc needs to be aware of the following threats that could negatively impact its business:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.